Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genesco (GCO) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Genesco (GCO) over the last 16 years, with Q4 2025 value amounting to $21000.0.

  • Genesco's Gains from Investment Securities fell 9697.41% to $21000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $98.1 million, marking a year-over-year decrease of 2142.06%. This contributed to the annual value of $156.5 million for FY2025, which is 2223.92% up from last year.
  • As of Q4 2025, Genesco's Gains from Investment Securities stood at $21000.0, which was down 9697.41% from -$56.5 million recorded in Q3 2025.
  • In the past 5 years, Genesco's Gains from Investment Securities ranged from a high of $154.2 million in Q1 2025 and a low of -$56.5 million during Q3 2025
  • Over the past 5 years, Genesco's median Gains from Investment Securities value was $7.3 million (recorded in 2021), while the average stood at $20.8 million.
  • As far as peak fluctuations go, Genesco's Gains from Investment Securities surged by 68326.05% in 2022, and later plummeted by 1226064.52% in 2025.
  • Genesco's Gains from Investment Securities (Quarter) stood at $3.9 million in 2021, then surged by 683.26% to $30.5 million in 2022, then crashed by 94.5% to $1.7 million in 2023, then crashed by 58.54% to $694000.0 in 2024, then plummeted by 96.97% to $21000.0 in 2025.
  • Its last three reported values are $21000.0 in Q4 2025, -$56.5 million for Q3 2025, and $385000.0 during Q2 2025.